Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ReposiTrak (TRAK) EBITDA (2016 - 2025)

Historic EBITDA for ReposiTrak (TRAK) over the last 16 years, with Q3 2025 value amounting to $1.8 million.

  • ReposiTrak's EBITDA rose 657.23% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 1366.61%. This contributed to the annual value of $7.0 million for FY2025, which is 1792.92% up from last year.
  • Latest data reveals that ReposiTrak reported EBITDA of $1.8 million as of Q3 2025, which was up 657.23% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, ReposiTrak's EBITDA peaked at $2.0 million during Q1 2025, and registered a low of $718297.0 during Q1 2021.
  • For the 5-year period, ReposiTrak's EBITDA averaged around $1.4 million, with its median value being $1.4 million (2023).
  • Its EBITDA has fluctuated over the past 5 years, first soared by 20317.74% in 2021, then tumbled by 827.98% in 2024.
  • Over the past 5 years, ReposiTrak's EBITDA (Quarter) stood at $957569.0 in 2021, then surged by 32.14% to $1.3 million in 2022, then rose by 14.22% to $1.4 million in 2023, then rose by 6.27% to $1.5 million in 2024, then increased by 17.91% to $1.8 million in 2025.
  • Its EBITDA was $1.8 million in Q3 2025, compared to $1.8 million in Q2 2025 and $2.0 million in Q1 2025.